Empagliflozin and its Fixed Drug Combinations (FDCs) have been launched under the brand names Glempa, Glempa –L and Glempa-M
Empagliflozin is used in the treatment of type-2 diabetes mellitus, chronic kidney disease and heart failure
The programme will take place on the 2nd Sunday of every month
Amplitude Surgical is a European MedTech leader in high-quality, lower-limb orthopaedic technologies
The European regulator will conduct a re-inspection of the facility to verify the compliance
This MoU marks a significant milestone in interdisciplinary research, paving the way for scientific advancements in homoeopathy
Overall investment in the US facility is estimated around US$50 million
Vidya will spark conversations around less discussed and important aspects of health, including intimate care and sleep issues
403 entries from 22 states covering 168 districts highlight groundbreaking initiatives vital to improving national nutrition metrics.
The study demonstrated equivalent efficacy, safety, immunogenicity, and pharmacokinetics between YESINTEK and the reference product Stelara
Subscribe To Our Newsletter & Stay Updated
